CD44 and colitis: We confirmed that Cur-HA-PLGA-NPs could target inflamed colitis tissue via HA-CD44 interaction with resident colonic epithelial cells and subsequently target activated macrophages using in vivo tissue accumulation and cellular uptake studies.